Patents by Inventor Lisa A. Boardman

Lisa A. Boardman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200263258
    Abstract: This document relates to methods and materials for assessing and/or treating mammals (e.g., humans) having one or more polyps (e.g., one or more colon polyps). For example, this document provides methods and materials for determining if a polyp (e.g., a polyp within a mammal having one or more polyps) is likely to recur and/or likely to progress to a cancer. This document also provides methods and materials for treating a mammal having one or more polyps.
    Type: Application
    Filed: February 14, 2020
    Publication date: August 20, 2020
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Lisa A. Boardman, Brooke R. Druliner
  • Publication number: 20150080702
    Abstract: Computer-implemented methods of improved quantitative interpretation of cell index profiles are provided.
    Type: Application
    Filed: September 10, 2014
    Publication date: March 19, 2015
    Inventors: Lisa A. Boardman, Kavishwar B. Wagholikar, Rajeev Chaudhry
  • Publication number: 20060188889
    Abstract: The present invention relates to novel marker sequences that are differentially expressed in cancer cells or tissue of a subject with cancerous conditions. The present invention also relates to assays for diagnosis, prognosis, staging, monitoring, therapeutic treatment, and marker sequence related agents including probes, primers, antibodies, and therapeutic compositions.
    Type: Application
    Filed: November 4, 2003
    Publication date: August 24, 2006
    Inventors: Christopher Burgess, Susan Myerow, Arunthathi Thiagalingam, Peter Maimonis, Gary Molino, Lawrence Burgart, Lisa Boardman, Stephen Thibodeau, Marcia Lewis
  • Publication number: 20060179496
    Abstract: This invention relates to novel nucleic acid sequences which are differentially expressed in cancer cells. The invention also relates to proteins and peptides encoded by the sequences, to diagnostic assays and therapeutic agents based on the sequences and proteins, and to probes, antisense constructs, and antibodies derived from the sequences and proteins or peptides. The subject nucleic acids have been found to be differentially expressed by tumor cells, particularly in colon cancer tissue.
    Type: Application
    Filed: July 26, 2005
    Publication date: August 10, 2006
    Inventors: Christopher Burgess, Jon Astle, Eddie Carroll, Theodore Catino, Poornima Dwivedi, Gary Molino, Arunthathi Thiagalingam, Marcia Lewis, Stephen Thibodeau, Lawrence Burgart, Lisa Boardman
  • Publication number: 20060134653
    Abstract: The present invention relates to nucleic acid sequences which are overexpressed in colorectal tumors which display a high level of microsatellite instability (MSI-H) vs. tumors displaying a low level of microsatellite instability (MSS), and can thus be used to identify MSI-H in a patient, and be used further to facilitate patient prognosis, monitor disease progression/regression, identify appropriate treatment regimes, and evaluate the efficacy of treatment.
    Type: Application
    Filed: April 13, 2005
    Publication date: June 22, 2006
    Inventors: Christopher Burgess, Theodore Catino, Gary Molino, Susan Myerow, Arunthathi Thiagalingam, Marcia Lewis, Stephen Thibodeau, Lisa Boardman, Lawrence Burgart